PHARMACY

GreenLight Rx introduces easy-to-open medicine vials

BY Alaric DeArment

SANTA ANA, Calif. — GreenLight Rx is offering a line of medicine bottles aimed at elderly people and those suffering from such conditions as arthritis, the company said.

The Santa Ana, Calif.-based manufacturer said it was working with retail pharmacies to help bring easy-to-open medicine containers to the public, particularly the EZ-pop, which comes in a variety of sizes and colors and is designed to make it easier to quickly and accurately identify medicines. According to a study by the Aging Research Center, 14.6% of older adults have difficulty opening plastic flip-top medicine bottles, and 66.3% have at least one limitation of capacity related to taking medicine.

"We have a growing population of older adults [who] find it difficult to open traditional prescription medicine containers," GreenLight Rx SVP John Kovacevich said. "Men and women with arthritis are also frustrated with their medicine vials and bottles, which are not only challenging, but can also cause great discomfort. We are working with major retail pharmacies to bring our EZ-pop containers to the public to help increase the ease of accessing medicines for millions of people."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

K.CARTER says:
Oct-14-2013 10:21 am

It should be noted that most of the existing bottles used by pharmacies are indicated as child resistant closures and that patients typically can request non CRC caps that are easier to deal with but in most cases this must be a patient request.

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Americans more likely than others to prefer generics, study finds

BY Alaric DeArment

RHINEBECK, N.Y. — Consumers in the United States are more likely than those in three other countries to say they prefer to receive generic drugs over branded drugs, according to a new study.

The study, by Phoenix Marketing International, included 810 consumers from the United States, Canada, the United Kingdom and France. Among respondents, 37% of American consumers expressed a preference for generics when they were available, compared with 22% of those in France, 12% in the United Kingdom and 21% in Canada.

Meanwhile, 29% of the French said the quality of generics was not as high as branded drugs, compared with 14% of Americans and 11% of Britons and Canadians. Seven percent of Americans said they would feel uncomfortable taking a generic drug for a serious illness, compared with 16% of French, 21% of Britons and 13% of Canadians. Americans were also most likely to say they had no concerns about taking generic drugs.

 

But despite concerns about generics among French consumers, generic use in France was the highest, with 73% saying they had taken a generic drug in the past two years, compared with 70% of Americans, 54% of Canadians and 36% of Britons.

 

 

 

Source: Phoenix Marketing International

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Ala. GOP representative proposes stopgap bill to fund FDA

BY Alaric DeArment

NEW YORK — A Republican congressman from Alabama has proposed a stopgap bill that would fund the Food and Drug Administration through the middle of December or until the government shutdown ends, though it is unlikely to pass in the Senate.

Last week, Rep. Robert Aderholt proposed the joint resolution, designed to ensure that the agency continues to receive funding until Dec. 15 or until the shutdown ends. However, Senate majority leader Harry Reid has said he will oppose such short-term funding bills. The federal government has remained shut down since Oct. 1, when Congress and the White House failed to reach an agreement on a fiscal year 2014 budget; Republicans in Congress have insisted that any budget agreement be tied to a delay or defunding of the Patient Protection and Affordable Care Act.

As part of its contingency staffing plan announced at the beginning of this month for the shutdown, the Department of Health and Human Services said the FDA would continue "limited" activities related to user-fee funded programs — such as reviews of generic drug applications — and such vital activities as consumer protection and high-risk recalls.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?